Search research articles
Contact Us
Filters
Showing results (131-140 of 139) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 139 results.
Journal of Medicinal Chemistry
|
March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor
Malcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 13, 2014
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2
James F Blake, John J Gaudino, Jason De Meese, et al.
Nature Communications
|
February 18, 2021
Genome sequences reveal global dispersal routes and suggest convergent genetic adaptations in seahorse evolution
Chunyan Li, Melisa Olave, Yali Hou, et al.
Journal of Medicinal Chemistry
|
November 11, 2014
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutation
Emily J Hanan, Charles Eigenbrot, Marian C Bryan, et al.
Journal of Medicinal Chemistry
|
May 27, 2016
Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
James F Blake, Michael Burkard, Jocelyn Chan, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 17, 2019
Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma
Sarah M Bronner, Karl A Merrick, Jeremy Murray, et al.
Science Translational Medicine
|
August 5, 2021
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis
Tianhe Sun, Zhiyu Huang, Wei-Ching Liang, et al.
Science Translational Medicine
|
December 14, 2022
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis
Joseph Chavarria-Smith, Cecilia P C Chiu, Janet K Jackman, et al.
Nature
|
May 6, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
Ivana Yen, Frances Shanahan, Jeeyun Lee, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 139) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 139 results.
Journal of Medicinal Chemistry
|
March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor
Malcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 13, 2014
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2
James F Blake, John J Gaudino, Jason De Meese, et al.
Nature Communications
|
February 18, 2021
Genome sequences reveal global dispersal routes and suggest convergent genetic adaptations in seahorse evolution
Chunyan Li, Melisa Olave, Yali Hou, et al.
Journal of Medicinal Chemistry
|
November 11, 2014
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutation
Emily J Hanan, Charles Eigenbrot, Marian C Bryan, et al.
Journal of Medicinal Chemistry
|
May 27, 2016
Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
James F Blake, Michael Burkard, Jocelyn Chan, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 17, 2019
Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma
Sarah M Bronner, Karl A Merrick, Jeremy Murray, et al.
Science Translational Medicine
|
August 5, 2021
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis
Tianhe Sun, Zhiyu Huang, Wei-Ching Liang, et al.
Science Translational Medicine
|
December 14, 2022
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis
Joseph Chavarria-Smith, Cecilia P C Chiu, Janet K Jackman, et al.
Nature
|
May 6, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
Ivana Yen, Frances Shanahan, Jeeyun Lee, et al.
Page
of 14